A Phase 3 Prospective Multiventer Randomized Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A Inhalation Solution Delivered via the PARI Investigational eFLOW Device Plus SOC versus SOC in the Treatment of

  • Nandavaram, Sravanthi (PI)
  • Rockich, Anna (CoI)
  • Baz, Maher (Former PI)
  • Sekela, Michael (Former PI)

Grants and Contracts Details

StatusActive
Effective start/end date5/24/1912/13/24

Funding

  • Covance: $48,046.00